Since the treatise by Thudichum in 1884 where he observed that "the fatty acids dissolve, while a body remains insoluble, which is of an alkaloid nature, and to which, in commemoration of the many enigmas which it presented to the enquirer, I have given the name of *Sphingosin*," much is known about the cellular and physiological functions of sphingosine and its phosphorylated derivative, sphingosine-1-phosphate (S1P), in mammals. S1P is produced in mammalian cells by two sphingosine kinase (SPHK) isoenzymes, SPHK1 and SPHK2, which differ in their temporal and spatial distribution (Maceyka et al., [@B9]). The SPHK/S1P pathway has been shown to regulate diverse physiological processes ranging from cellular proliferation to survival and pathophysiological processes like osteoporosis, diabetes, and cancer. Mammalian SPHKs can be regulated by numerous effectors. For example, the mammalian SPHK1 is activated by its interaction with TRAF2 (TNF receptor-associated factor 2), with SPHK1 acting as a co-factor for the E3 ligase activity of TRAF2 (Alvarez et al., [@B1]). The mammalian SPHK2 is part of the repressor complex with histone H3 and histone deactylases (HADCs) in the nucleus, and the resulting nuclear production of S1P by SPHK2 regulates histone acetylation and transcription (Hait et al., [@B5]).

In plants, work from the Wang laboratory showed that the two tonoplastic SPHK1 and SPHK2 isoenzymes from *Arabidopsis thaliana* can be activated by phospholipase D α1 (PLDα1)-derived phosphatidic acid (PA) species, and that SPHK-derived phytosphingosine-1-phosphate (phyto-S1P) acts upstream of PLDα1 (see this review by Guo and Wang). Guo and Wang have provided a comprehensive review of the crosstalk between the sphingolipid and phospholipid pathways and their potential roles in regulating signaling processes. However, two questions remain: (1) how do PAs activate SPHKs, and (2) how does phyto-S1P activate PLD?

Firstly, work in the mid 1990s by Olivera et al. may provide some clues to the underlying mechanism(s). They showed that mammalian SPHKs can be activated by phosphatidylserine, and to a lesser extent by lysophosphatidylserine, phosphatidylinositol, phosphatidylinositol bisphosphate, cardiolipin, and PA. These SPHK activators are acidic phospholipids and their ability to activate SPHK activity suggests the potential importance of the negative charges on the phospholipid molecules. This is supported by the observation that diacylglycerol, which is structurally similar to PA but lacking the phosphate group did not activate SPHKs (Olivera et al., [@B13]). The situation appears to differ in the case of *A. thaliana* SPHK1 and SPHK2 as these enzymes do not appear to interact with other phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylinositol, phosphatidylserine, lysophosphatidylcholine, and lysophosphatidylethanolamine (Guo et al., [@B4]). In contrast to mammalian SPHK1 and SPHK2 that are localized mainly in the cytosol and the nucleus, respectively, *A. thaliana* SPHK1 and SPHK2 are primarily associated with the tonoplast (Marion et al., [@B10]; Guo et al., [@B4]), and thus it remains to be determined if their activation by PA only may be due to their tonoplastic localization. Given the diversity in phospholipid classes and species in eukaryotic cells, it will be interesting, while at the same time challenging, to determine the effects of particular phospholipids on plant SPHK activities, and Wang and co-workers have initiated work in this regard with respect to different PA species (Guo et al., [@B4]). Additionally, it can be speculated that PA targets (see this review by Guo and Wang) can phosphorylate SPHKs, leading to their activation as previously shown in mammals (Pitson, [@B14]). Clearly, solving the SPHK structures will be crucial for understanding the regulatory mechanisms that control these enzymes.

Secondly, work from the Wang laboratory showed that phyto-S1P does not activate PLDα1 directly *in vitro* (Guo et al., [@B3]). S1P and phyto-S1P were found to stimulate an intracellular calcium increase (Ng et al., [@B12]; Kim et al., [@B7]), and calcium is a key factor required for PLDα1 activity (see this review by Guo and Wang). Consequently, phyto-S1P may increase cytoplasmic calcium to promote PLDα1 translocation, resulting in PLDα1 activation. On the other hand, work on two *A. thaliana* mutants disrupted in the Gα subunit of heterotrimeric G protein showed that they are incapable of initiating stomatal closure when they are challenged by phyto-S1P, suggesting that Gα functions downstream of SPHK/phyto-S1P (Coursol et al., [@B2]). Additionally, it was shown that PLDα1 physically interacts with Gα (Mishra et al., [@B11]), and thus phyto-S1P may activate Gα to stimulate PLDα1. Network inference also predicted a positive regulation of Gα by S1P, which in turn positively regulates PLD/PA (Li et al., [@B8]). The resulting effect on stomatal closure is likely to be mediated by PA inhibition of the type 2C protein phosphatase ABI1, a negative regulator of ABA signaling (Li et al., [@B8]). It will be interesting to see if as predicted by Li et al. ([@B8]), ABA inhibition of ABI1 phosphatase activity is impaired in *sphk* mutants unable to produce phyto-S1P.

We envisage that determination of the structure--activity relationships between phospholipids and SPHKs will yield interesting clues as to the underlying mechanisms for phospholipid activation of SPHKs. Additionally, it will be interesting to see if non-seed land plants and monocots show similar trends and responses as sphingosine is present in these plants (Islam et al., [@B6]), and may have an effect on which long chain bases are used in the SPHK and PLD-mediated pathways.
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